Cargando…
Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
The development of CFTR modulator therapies significantly changed the treatment scheme of people with cystic fibrosis. However, CFTR modulator therapy is still a life-long treatment, which is not able to correct the genetic defect and cure the disease. Therefore, it becomes crucial to understand the...
Autores principales: | Yi, Buqing, Dalpke, Alexander H., Boutin, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010178/ https://www.ncbi.nlm.nih.gov/pubmed/33816324 http://dx.doi.org/10.3389/fcimb.2021.548613 |
Ejemplares similares
-
Commensal Bacteria in the Cystic Fibrosis Airway Microbiome Reduce P. aeruginosa Induced Inflammation
por: Tony-Odigie, Andrew, et al.
Publicado: (2022) -
A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis
por: Metzger, Marisa I., et al.
Publicado: (2021) -
CFTR Modulators Dampen Aspergillus-Induced Reactive Oxygen Species Production by Cystic Fibrosis Phagocytes
por: Currie, Alexander J., et al.
Publicado: (2020) -
CFTR Modulators Restore Acidification of Autophago-Lysosomes and Bacterial Clearance in Cystic Fibrosis Macrophages
por: Badr, Asmaa, et al.
Publicado: (2022) -
Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study
por: Hahn, Andrea, et al.
Publicado: (2020)